Versican Plus Pi/L4

Authorised

This medicine is authorised for use in the European Union

canine parainfluenza virus and Leptospira

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website.

Versican Plus Pi/L4 : EPAR - Summary for the public

Reference Number: EMA/336268/2014

Product information

Versican Plus Pi/L4 : EPAR - Product Information

Versican Plus Pi/L4 : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Versican Plus Pi/L4
• Active substance:
  Canine parainfluenza type 2 virus, strain CPiV-2 Bio 15 (live attenuated), Leptospira interrogans serogroup Australis serovar Bratislava, strain MSLB 1088, L. interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae, strain MSLB 1089, L. interrogans serogroup Canicola serovar Canicola, strain MSLB 1090 and L. kirschneri serogroup Grippotyphosa serovar Grippotyphosa, strain MSLB 1091 (all inactivated)
• International non-proprietary name (INN) or common name:
  canine parainfluenza virus and Leptospira

Authorisation details

• EMA product number:
  EMEA/V/C/003683

Assessment history

Changes since initial authorisation of medicine

Versican Plus Pi/L4 : EPAR - Procedural steps taken and scientific information after authorisation

CVMP post-authorisation summary of positive opinion for Versican Plus Pi/L4

Adopted Reference Number: EMA/CVMP/574869/2018

Initial marketing authorisation documents

CVMP summary of positive opinion for Versican Plus Pi/L4

Adopted Reference Number: EMA/CVMP/301775/2014